Acutus Medical, Inc. (AFIB)
OTCMKTS
· Delayed Price · Currency is USD
0.0481
+0.0001 (0.21%)
Dec 26, 2024, 12:40 PM EST
Acutus Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Revenue | 15.38 | 7.16 | 3.03 | 17.26 | 8.46 | 2.84 | Upgrade
|
| Revenue Growth (YoY) | - | 136.36% | -82.44% | 103.96% | 198.45% | 30.93% | Upgrade
|
| Cost of Revenue | 15.49 | 10.3 | 4.94 | 32.93 | 15.89 | 9.24 | Upgrade
|
| Gross Profit | -0.11 | -3.14 | -1.91 | -15.66 | -7.43 | -6.41 | Upgrade
|
| Selling, General & Admin | 12.44 | 14.07 | 20.32 | 63.52 | 50.36 | 26.65 | Upgrade
|
| Research & Development | 0.73 | 3.48 | 3.12 | 36.68 | 33.45 | 23.03 | Upgrade
|
| Operating Expenses | 13.17 | 17.55 | 23.43 | 100.21 | 83.81 | 49.68 | Upgrade
|
| Operating Income | -13.28 | -20.69 | -25.34 | -115.87 | -91.24 | -56.08 | Upgrade
|
| Interest Expense | -5.93 | -5.66 | -5.15 | -5.68 | -5.51 | -22.27 | Upgrade
|
| Interest & Investment Income | 1.01 | 2.59 | 0.87 | 0.12 | 0.44 | 1.16 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.75 | 2.94 | 0.03 | - | -5.56 | -1.92 | Upgrade
|
| EBT Excluding Unusual Items | -16.45 | -20.82 | -29.59 | -121.43 | -101.86 | -79.11 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | - | -0.2 | Upgrade
|
| Impairment of Goodwill | - | - | -12.03 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 11.25 | 9.08 | 79.47 | - | - | - | Upgrade
|
| Asset Writedown | - | - | - | - | - | -15.79 | Upgrade
|
| Other Unusual Items | - | -0.12 | -9 | 3.75 | -0.1 | -1.95 | Upgrade
|
| Pretax Income | -5.21 | -11.86 | 28.85 | -117.68 | -101.96 | -97.04 | Upgrade
|
| Income Tax Expense | 0.06 | 0.06 | 0.02 | - | 0.02 | - | Upgrade
|
| Earnings From Continuing Operations | -5.27 | -11.92 | 28.83 | -117.68 | -101.98 | -97.04 | Upgrade
|
| Earnings From Discontinued Operations | -36.64 | -69.74 | -68.45 | - | - | - | Upgrade
|
| Net Income | -41.91 | -81.66 | -39.62 | -117.68 | -101.98 | -97.04 | Upgrade
|
| Net Income to Common | -41.91 | -81.66 | -39.62 | -117.68 | -101.98 | -97.04 | Upgrade
|
| Shares Outstanding (Basic) | 30 | 29 | 28 | 29 | 11 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 30 | 29 | 37 | 29 | 11 | 1 | Upgrade
|
| Shares Change (YoY) | 2.13% | -21.69% | 29.66% | 151.19% | 1597.67% | 23.11% | Upgrade
|
| EPS (Basic) | -1.41 | -2.81 | -1.39 | -4.11 | -8.94 | -144.41 | Upgrade
|
| EPS (Diluted) | -1.41 | -2.81 | -1.06 | -4.11 | -8.94 | -144.41 | Upgrade
|
| Free Cash Flow | -44.8 | -63.34 | -89.15 | -109.66 | -96.39 | -59.38 | Upgrade
|
| Free Cash Flow Per Share | -1.51 | -2.18 | -2.40 | -3.83 | -8.45 | -88.37 | Upgrade
|
| Gross Margin | -0.72% | -43.79% | -63.02% | -90.73% | -87.72% | -225.92% | Upgrade
|
| Operating Margin | -86.40% | -288.74% | -836.13% | -671.19% | -1077.93% | -1977.54% | Upgrade
|
| Profit Margin | -272.56% | -1139.91% | -1307.03% | -681.71% | -1204.88% | -3421.69% | Upgrade
|
| Free Cash Flow Margin | -291.35% | -884.10% | -2941.11% | -635.20% | -1138.87% | -2093.83% | Upgrade
|
| EBITDA | -13.24 | -20.49 | -24.78 | -109.47 | -88.02 | -53.73 | Upgrade
|
| EBITDA Margin | -86.13% | -286.07% | - | - | - | - | Upgrade
|
| D&A For EBITDA | 0.04 | 0.19 | 0.56 | 6.39 | 3.22 | 2.35 | Upgrade
|
| EBIT | -13.28 | -20.69 | -25.34 | -115.87 | -91.24 | -56.08 | Upgrade
|
| EBIT Margin | -86.40% | -288.74% | - | - | - | - | Upgrade
|
| Effective Tax Rate | - | - | 0.05% | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.